Valued at a market capitalization of $7.9 billion, The Mosaic Firm (MOS) is a outstanding producer and marketer of concentrated phosphate and potash crop vitamins. The Tampa, Florida-based firm owns and operates mines and manufacturing services, which produce concentrated phosphate crop vitamins and phosphate-based animal feed components below the Biofos and Nexfos manufacturers.
The corporate is anticipated to launch its Q1 2026 earnings report shortly. Forward of the occasion, analysts count on the corporate’s EPS to be $0.18 on a diluted foundation, down 63.3% from $0.49 within the year-ago quarter. The corporate has surpassed Wall Road’s EPS estimates in two of its final 4 quarters, whereas lacking on two different events.
For the present 12 months, analysts challenge the corporate’s EPS to be $1.65, down 27.3% from $2,27 in fiscal 2025. Nonetheless, its EPS is anticipated to rebound, rising 54.6% 12 months over 12 months to $2.55 in fiscal 2027.
MOS inventory has declined 9.9% over the previous 52 weeks, underperforming the S&P 500 Index’s ($SPX) 34.9% rise and the State Road Supplies Choose Sector SPDR ETF’s (XLB) 28.5% return throughout the identical timeframe.
Mosaic shares rose over 4% on Apr. 16, pushed by issues {that a} potential U.S. blockade of the Strait of Hormuz might disrupt international fertilizer provide, boosting sector sentiment.
Analysts are skeptical of MOS, with the inventory having a “Maintain” ranking total. Among the many 18 analysts masking the inventory, 5 are recommending a “Robust Purchase,”11 analysts advise a “Maintain,” and two counsel “Robust Promote” for the inventory. MOS’s common analyst value goal is $30.25, indicating an upside of 23.1% from the present ranges.
On the date of publication, Kritika Sarmah didn’t have (both instantly or not directly) positions in any of the securities talked about on this article. All data and information on this article is solely for informational functions. This text was initially printed on Barchart.com
